Skip to main content

Centene Value Stock - Dividend - Research Selection

Centene

ISIN: US15135B1017 , WKN: 766458

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Centene Corporation operates as a diversified and multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. It operates through two segments, Managed Care and Specialty Services. The Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children\'s health insurance program, long-term care, foster care, and dual eligible individual, as well as aged, blind, or disabled programs. Its health plans include primary and specialty physician care, inpatient and outpatient hospital care, emergency and urgent care, prenatal care, laboratory and X-ray services, home-based primary care, transportation assistance, vision care, dental care, immunizations, prescriptions and limited over-the-counter drugs, specialty pharmacy, therapies, social work services, and care coordination. The Specialty Services segment provides pharmacy benefits management services; health, triage, wellness, and disease management services; vision and dental services; correctional healthcare services; home based primary care services; and integrated long-term care services, as well as care management software that automate the clinical, administrative, and technical components of care management programs. This segment offers its services and products to state programs, correctional facilities, healthcare organizations, employer groups, military service members and their families, and other commercial organizations. The company provides its services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in St. Louis, Missouri.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Align Technology, Envista, Centene, Amphastar Pharmaceuticals, and Oscar Health Shares Plummet, What You Need To Know

2025-10-10
A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump.

Here’s What Impacted Centene Corporation (CNC) in Q3

2025-10-10
Oakmark Funds, advised by Harris Associates, released its “Oakmark Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. In the third quarter, the fund underperformed its benchmark, the S&P 500 Index, but outperformed the benchmark since inception. The largest contributors to performance were financials and energy, at the sector level, while […]

Don't Waste Your Time Timing Bubbles: Subscriptions Make This Market Nothing Like 1999

2025-10-10
Discover why S&P 500 companies’ shift to subscription models strengthens earnings consistency and makes equities outperform bonds.

Winners and losers from 2026 Medicare Advantage star ratings

2025-10-10
The CMS quietly released anticipated star ratings data Thursday night. Humana and Aetna saw enrollment in highly rated plans fall, while Elevance’s and Centene’s stars improved and UnitedHealthcare’s stayed stable.

Mizuho Maintains Centene (CNC) Neutral Recommendation

2025-10-10

How Recent Developments Are Shaping the Story and Outlook For Centene

2025-10-09
Centene’s stock price target has inched upward, with consensus analyst estimates rising from $33.94 to $34.63. This subtle shift reflects updated analyst outlooks as market viewpoints evolve, influenced by recent company updates and sector trends. To understand how analysts navigate these revisions and what they might mean for investors, read on to explore how you can stay updated as the story continues to develop. What Wall Street Has Been Saying Recent analyst research on Centene has...

CVS Health's Aetna Advances Initiative to Curb Hospital Readmissions

2025-10-09
CVS company, Aetna, expands its Aetna Clinical Collaboration program to 10 hospitals, aiming to cut readmissions and ease hospital workloads.

Could Medicaid Headwinds Reshape Centene's (CNC) Pricing Power and Long-Term Strategy?

2025-10-09
Centene recently announced it will report its third-quarter results later this month, following a period of heightened attention after withdrawing its 2025 earnings guidance due to rising Medicaid costs and changing enrollment patterns. This development highlights ongoing uncertainty in the Medicaid segment and the company's need to implement corrective pricing strategies in response to unexpected trends and rising patient costs. We'll examine how these recently disclosed Medicaid cost...

Democrats Want to Extend Obamacare Subsidies. What That Means for Centene, Tenet, and Other Stocks.

2025-10-08
Ever since President Donald Trump won a return ticket to the White House last November, investors have been anticipating the end of federal subsidies that have slashed the prices of health insurance premiums for millions of Americans. Insurers like Centene and Oscar Health were bracing for major drops in enrollment in the plans they sell on the ACA exchanges, and hospital companies like HCA Healthcare and Tenet Healthcare were expecting to treat fewer patients.

WellCare of North Carolina Invests in More than 40 Local Nonprofits to Support Community Health Across the State

2025-10-08
WellCare of North Carolina (WellCare), an NC Medicaid health plan and subsidiary of Centene Corporation (NYSE: CNC), is supporting health-related resources for communities across North Carolina through over $1.6M of investments in local nonprofit organizations. This funding, which began in 2024 and will continue throughout 2025, will help support critical healthcare needs such as assisting with food and nutrition, clothing, utilities, housing, and interpersonal safety for North Carolina's most v